Full Course Description


The Ultimate One-Day Diabetes Course

As healthcare professionals, we encounter patients with diabetes, pre-diabetes, and metabolic syndrome daily—no matter our specialty. With diabetes management becoming increasingly complex, it’s crucial to stay ahead of the curve with access to the 2025 ADA guidelines, prescribing algorithms, innovations in technology, and best practice strategies to prevent complications.


If we are not on top of new diabetes evidence and practice-based protocols, the delivery of diabetes care can be suboptimal.  This could unknowingly increase the risk for acute and chronic complications such as cardiovascular disease, renal failure, and neuropathy.  As more and more people are diagnosed with pre-diabetes and diabetes, there has never been a more important time to optimally intervene.


Diabetes expert Tracey Long PhD, MS, MSN, APRN-BC, CDCES, CCRN, CNE, COI, will advance your diabetes insights and guide you toward enhanced clinical decision making for individualized diabetes care.  You’ll learn current evidence-based pharmacological (including 3.5 pharmacology CE hours) and non-pharmacological approaches to glucose control. Gain practical skills to assess and treat both diabetic and pre-diabetic patients. Expand proficiency in emerging diabetes technologies.  And strengthen patient education strategies to promote adherence and lifestyle modification.


Through case-based discussions and highly requested topics, develop the skills to personalize care and optimize patient outcomes. Leave with up-to-date techniques and new confidence in your ability to prevent and manage diabetes more effectively. Your expertise starts here!

 

Program Information

Outline

Diabetes Incidence, Risk Factors & Diagnostic Criteria

  • Incidence & prevalence: Current statistics
  • Risk factors and causes: Identifying modifiable and non-modifiable risk factors (age, ethnicity, family history, obesity, lifestyle)
  • Clinical manifestations: by body systems
  • Diagnostic criteria: ADA 2025 guidelines for diagnosing diabetes and pre-diabetes using A1c, fasting glucose, and OGTT
Pathophysiology of Diabetes
  • Type 1 diabetes: Autoimmune destruction of pancreatic beta cells
  • Type 2 diabetes: Insulin resistance and impaired insulin secretion
  • Pre-diabetes & metabolic syndrome: Early pathophysiological changes
  • Gestational diabetes: Mechanisms and pregnancy-related risks
ADA Guidelines & Goals for Management
  • ADA Standards of Care 2025: Review of the most recent guidelines
  • Goals of care: Blood glucose, blood pressure, BMI, and lipid targets, smoking cessation
  • Individualized care plans: Tailored treatment goals based on patient comorbidities, age, and risk factors
Treatment Strategies 7 “MnMs”
  • Movement
  • Mass Reduction
  • Meal Planning
  • Monitoring
Monitoring with Technology
  • Traditional blood glucose methods: Fingerstick blood glucose and A1c
  • Continuous glucose monitoring (CGM): Devices, benefits, and interpreting data
  • New technologies: Advancements in non-invasive glucose monitoring
  • Monitoring: Labs, weight
Pharmacological Management of Diabetes
  • Oral medications: Metformin, SGLT-2 inhibitors, DPP-4 inhibitors, sulfonylureas, etc
  • Injectable therapies: Insulin, GLP-1 receptor agonists
  • Latest medications: Review of new drugs in the 2025 guidelines
  • Combination therapies: Strategies for optimizing glucose control
Acute & Chronic Complications
  • Acute complications: Hypoglycemia, hyperglycemia, diabetic ketoacidosis, hyperosmolar hyperglycemic state
  • Chronic complications: Neuropathy, retinopathy, cardiovascular disease, nephropathy, and diabetic foot ulcers
Considerations to Enhance Patient Outcomes
  • Addressing mental health concerns from diabetes diagnosis
  • Diabetes teaching tips for patients
  • Technological advances on the horizon
Take away resources

Objectives

  1. Utilize the ADA 2025 diagnostic criteria for diabetes and pre-diabetes using appropriate lab values and tests.
  2. Determine the physiological changes in diabetes as they relate to clinical symptoms and disease progression.
  3. Develop individualized care plans based on patient characteristics, including specific blood glucose, blood pressure, and lipid targets.
  4. Formulate effective lifestyle intervention plans, including dietary changes, physical activity, and weight management.
  5. Choose patient education tools that enhance adherence and empower self-management.
  6. Evaluate continuous glucose monitoring data for patient care.
  7. Evaluate the benefits and limitations of emerging blood glucose monitoring technologies.
  8. Analyze ADA & AACE 2025 algorithms for oral and injectable medications.
  9. Choose combination therapy strategies that optimize glucose control in patients.
  10. Determine best practices to prevent and manage long-term diabetes complications.

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physician Assistants
  • Clinical Nurse Specialists
  • Dietitians
  • Certified Diabetes Care and Education Specialists

Copyright : 04/10/2025

Diabetes Medication Therapy

Nicole Pezzino, PharmD, BCACP, CDCES, delivers a comprehensive update to manage diabetes through the lens of medication therapy. She will delve into an in-depth analysis of mediation-treatment options from the guidelines, highlighting the evolving landscape of treatment modalities. The comprehensive breakdown of commonly prescribed diabetes medications provides a detailed understanding of their indications, efficacy including A1c reduction, as well as newly identified benefits related to ASCVD, HF, and CKD. You will gain valuable insights into the latest safety considerations, including potential side effects, warnings, precautions, contraindications, and advanced monitoring protocols. Each medication will highlight important counseling points and patient tips to improve medication adherence, thereby enhancing patient outcomes. With the provision of clinical pearls, the presentation aims to equip healthcare professionals with the latest updates on diabetes medications, enabling you to make informed decisions and optimize treatment strategies in line with the most recent medical advancements.

Program Information

Objectives

  1. Analyze the medication treatment options from the 2024 ADA Standards of Care for Diabetes.
  2. Compare the treatment algorithm from the ADA and AACE/ACE guidelines for diabetes and individualize medications based on patient’s other comorbidities.
  3. Examine the efficacy, safety and recommended counseling points for the drugs reviewed.
  4. Summarize appropriate clinical pearls and lifestyle modifications for patients with diabetes.

Outline

Diabetes Medication Guideline Updates

  • Including 8 organ dysfunctions
Breakdown of Most Commonly Prescribed Diabetes Medications
  • Medication name ((Brand (Generic))
  • Indication – Including dosing and mechanism of action
  • Efficacy – A1c reduction, ASCVD/HF/CKD benefits
  • Safety – Side effects, warnings/precautions, contraindications, monitoring
  • Adherence – counseling points and patient tips
  • Clinical pearls/takeaways
Key Takeaways
  • Lifestyle modification
  • Call to action
  • Replication

Target Audience

  • Nurse Practitioners
  • Physicians
  • Physician Assistants
  • Nurses

Copyright : 03/21/2024

Breaking Free from Diet Culture: A New Path for Diabetes Care

Food is medicine when our relationship with food is healing, not harmful. This is especially true for our clients with prediabetes and diabetes. Mindful Eating is a weight-inclusive approach to food and eating that compassionately returns us to the present moment. Mindfulness-based approaches are an effective way to counter the internalized stigma that has been absorbed from our weight-focused culture, which unintentionally blames people with diabetes. As a provider, you need effective tools to help clients heal their relationship with food, eating, and body image so food can become medicine. In this session, you will learn how to talk about mindful eating using motivational interviewing techniques. Using MI to explain key mindful eating concepts fosters insight and enables clients with elevated blood sugar to reach for sustainable self-care. This weight-inclusive approach transforms our relationship with food because we feel seen, heard, and valued, regardless of weight.

Program Information

Objectives

  1. Critically analyze and identify three specific ways diet culture influences diabetes management practices, contributing to an imbalanced focus on dietary restrictions over holistic care. 
  2. Demonstrate the ability to apply mindful eating principles in clinical scenarios with clients who have diabetes, utilizing at least two strategies that encourage choice, balance, insight into barriers, and change opportunities for clients. 
  3. Construct and implement care plan for clients with diabetes, integrating the four factors of diabetes care (Dietary, Lifestyle, Medicine, and Environment). 

Outline

Mindful Eating and Diabetes Management 

  • Key concepts of Mindful Eating and their relevance to diabetes care 
  • Differentiate mindful eating from dieting to emphasize direct body awareness and cues 

 
Addressing Weight Bias in Diabetes Care 

  • Impact of weight bias, stigma on patient care and outcomes 
  • Strategies to promote a non-judgmental, inclusive care setting 

 
Four Factors of Diabetes 

  • A deep dive into the critical elements of diabetes care, with tools to educate and empower clients. 
  • Go beyond ‘just’ blood sugar 
  • Holistic exploration of nutrition, physical activity, stress management, and emotional well-being 
  • Effective methods to communicate these factors to clients, fostering understanding and engagement 

 
Motivational Interviewing for Inclusive Care & Sustainable Long-Term Behavior Change 

  • Overview of the technique and its application in healthcare 
  • The Spirit of MI: Techniques to build rapport, fostering an environment of trust and openness 
  • Using motivational interviewing to support non-judgmental, patient-centered diabetes care 
  • Use MI to present mindful eating to clients in ways that foster sustainable lifestyle changes 

Target Audience

  • Athletic Trainers
  • Chiropractors
  • Dietitians
  • Exercise Physiologists
  • Nurse Practitioners
  • Nurses
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Physical Therapists
  • Physical Therapy Assistants
  • Physician Assistants
  • Physicians
  • Strength and Conditioning Coaches
  • Other Rehabilitation and Fitness Professionals 

Copyright : 12/18/2024

Diabetes and Cardiovascular Disease

Tracey Long PhD, MS, MSN, RN, APRN-BC, CDCE, CCRN, CNE, COI, will provide you with a comprehensive understanding of the intricate relationship between diabetes and cardiovascular disease (CVD). As these two chronic conditions often coexist and exacerbate each other, it is crucial that you are equipped with the knowledge and skills to manage them effectively. Explore pathophysiological connections, assess risk factors, and learn the very latest evidence-based strategies for prevention and management. Key aspects of patient education, including the promotion of lifestyle modifications to reduce cardiovascular risks in diabetic patients, will be incorporated. 

New research has concluded there is a significant relationship between diabetes and cardiovascular disease, making it essential for clinicians to understand diagnosis, prevention, and pharmacological strategies for optimal patient outcomes. 

Program Information

Objectives

 

  1. Analyze the pathophysiological relationship between diabetes and cardiovascular disease. 

  1. Explore key risk factors that contribute to the development of cardiovascular complications in diabetic patients. 

  1. Implement evidence-based interventions to manage and reduce the risk of cardiovascular disease in diabetic patients. 

  1. Evaluate the effectiveness of interventions in reducing cardiovascular disease risk among diabetic patients through case studies and clinical scenarios. 

Outline

Pathophysiology of Diabetes and Cardiovascular Disease (CVD) 

  • Mechanisms linking diabetes to cardiovascular complications 

  • Epidemiology and prevalence of coexisting diabetes and CVD 

  • Impact of hyperglycemia on the cardiovascular system 

  • Role of insulin resistance and inflammation 

Risk Factors and Assessment 

  • Risk factors for CVD in diabetic patients (e.g., hypertension, dyslipidemia, obesity) 

  • Screening and assessment tools for cardiovascular risk in diabetes 

  • Early identification and management of risk factors 

Interventions and Management Strategies 

  • Evidence-based approaches to managing diabetes and reducing cardiovascular risk 

  • Pharmacological interventions (e.g., antihyperglycemic agents, antihypertensives, statins) 

  • Lifestyle modifications: Diet, exercise, weight control, smoking cessation 

  • Patient education and self-management support 

Case Studies and Clinical Applications 

  • Real-world scenarios demonstrating the diabetes-CVD connection 

  • Interactive discussion on best practices and challenges in care 

Target Audience

  • Physicians
  • Physician Assistants
  • Nurses

Copyright : 09/05/2024

The Highs and Lows of Diabetes Management in Pregnancy

Unlock the critical skills needed to manage diabetes in pregnancy. Gain expertise in distinguishing pregestational and gestational diabetes, delve into the pharmacokinetic profiles of various insulin products and understand the complexities of insulin resistance during pregnancy. Learn to create and apply tailored insulin regimens, ensuring optimal care for pregnant patients with diabetes.

Program Information

Objectives

  1. Differentiate diagnostic criteria of pregestational diabetes versus gestational diabetes.
  2. Analyze the differences of insulin products pharmacokinetic profiles.
  3. Discuss insulin resistance in pregnancy.
  4. Apply and create insulin regimens for a pregnant patient.

Outline

Overview of Pre-Gestational Diabetes

  • Diabetes Burden
  • Diagnostic Criteria

Impact on Pregnancy

  • Maternal
  • Fetal
  • Medication Changes

Gestational Diabetes

  • Risk Factors
  • Early Screening Strategies
  • Glucose Tolerance Testing
  • Placenta Induced Insulin Resistance
  • Comparison of Insulin Needs During Pregnancy

Management of Gestational Diabetes

  • A1C Goals
  • Lifestyle Management
  • Insulin Initiations
  • Insulin Adjustments

Other Considerations

Post Partum Adjustments

Target Audience

  • Nurses
  • NPs
  • PAs
  • MDs
  • DOs
  • Pharmacists

Copyright : 06/12/2024

Revolution in Diabetes Care

Diabetes management is evolving rapidly, with new medications, updated guidelines, and innovative approaches to optimizing glycemic control while minimizing complications. This one-hour session will explore the latest updates in pharmacologic treatment for diabetes, providing a comprehensive review of the nine major classes of diabetes medications, their mechanisms of action, and key clinical considerations.

Through an engaging lecture and interactive case study, gain practical insights into selecting the most effective treatments based on individual patient needs. Whether managing type 1 or type 2 diabetes, take away the knowledge to implement evidence-based strategies for improved patient outcomes. Stay ahead of the latest advancements and refine your approach to diabetes pharmacology!

Program Information

Objectives

  1. Evaluate the mechanism of action, benefits, and potential side effects of the nine major classes of current diabetes medications.
  2. Analyze pharmacologic treatment guidelines for diabetes stand the implications for patient care.
  3. Apply updated pharmacologic knowledge to practical diabetes medication decisions.

Outline

Diabetes Medication Classes

  • Biguanides (Metformin) – First-line therapy, insulin sensitivity
  • Sulfonylureas (Glipizide, Glyburide, Glimepiride) – Insulin secretion
  • Meglitinides (Repaglinide, Nateglinide) – Rapid-acting insulin secretion
  • Thiazolidinediones (Pioglitazone, Rosiglitazone) – Insulin sensitivity, risks
  • DPP-4 Inhibitors (Sitagliptin, Linagliptin, Saxagliptin) – Incretin effects
  • GLP-1 Receptor Agonists (Semaglutide, Liraglutide, Dulaglutide) – Weight loss, cardiovascular benefits
  • SGLT-2 Inhibitors (Empagliflozin, Dapagliflozin, Canagliflozin) – Renal and cardiovascular benefits
  • Insulin Therapy (Rapid, Basal, Mixed) – Individualizing therapy
  • Amylin analogues (Pramlintide) – Adjunct therapy for type 1 and type 2
Case Study Application to Practice
  • Patient scenario with comorbidities, A1C levels, and treatment barriers
  • Select appropriate pharmacologic interventions
  • Adjust therapy based on patient response and side effects

Target Audience

  • NPs
  • APRNs
  • PAs
  • PharmDs
  • MDs
  • DOs

Copyright : 05/16/2025

Managing the Diabetic Foot

According to the National Diabetes Statistics Report, 37.3 million adults are diabetic, 8.5 million are yet undiagnosed and 96 million are prediabetic. Up to 20% of these will develop a diabetic foot ulcer, 80% of which will result in amputation. It doesn’t have to be this way! This session will provide the assessment skills, common causes, complications, and treatment strategies both to prevent ulceration and achieve healing in these difficult cases.

Program Information

Objectives

  1. Assess the characteristics of a diabetic foot ulcer. 
  2. Appraise the factors that contribute to the development of a diabetic foot ulcer. 
  3. Apply evidenced based interventions to promote healing. 
  4. Determine when to refer to other disciplines to complement healing. 
  5. Develop individualized treatment programs for each patient. 

Outline

Comorbidities 

  • Coronary artery disease 
  • Large and small vessel damage 
  • Depression 
Causes of Foot Ulcerations 
  • Peripheral & autonomic nervous system neuropathy 
  • Mechanical stress 
  • Foot deformities 
Assessment and Diagnostic Tools 
  • Loss of protective sensation 
  • Semmes- Weinstein 5.07 monofilament 
  • 128hz tuning fork 
  • Capillary refill 
  • ABI 
Managing the Diabetic Foot 
  • L.E.A.P 
  • Callus management 
  • Footwear 
Characteristics of a Diabetic Foot Ulcer 
  • Location 
  • Shape 
  • Exudate 
  • Wound bed appearance 
Assessment of Bacterial Burden 
  • Signs of infection 
  • Silent infection 
  • Quantitative tissue biopsy 
  • Wound cultures 
  • Proper wound cleansing 
Orthopedic Assessment 
  • X ray 
  • Osteolysis 
  • Charcot foot 
  • Total contact casting 
  • Offloading boots 
  • Custom shoe inserts 
  • Osteomyelitis 
Vital Role of Dietitian 
  • Protein & carbohydrates 
  • RDA’s for adults 
  • Amino acids 
  • Nitric oxide 
Optimal Wound Healing Requirements 
  • Too wet/too dry 
  • Dressings 
  • Biologics 
  • Silvers 
  • Cytotoxics 
Therapy Modalities 
  • High and low frequency ultrasound 
  • Pulsed lavage/jet ox 
  • Hyperbaric oxygen 
  • Topical/transcutaneous oxygen 
  • Electric Stimulation (HVPG) 
  • MIRE 
  • Wound Vac 

Target Audience

  • Nurses
  • Nurse Practitioners
  • Physicians Assistants
  • Physical Therapists

Copyright : 10/20/2022

Life Threatening Diabetic Emergencies

With the high prevalence of 38 million Americans in the US with diabetes and almost ¼ of the US population with prediabetes, healthcare professionals need to know how to respond to diabetic emergencies. Emergency nurses need to be aware of the pathophysiology and treatment standards, as the acceleration of available diabetic medications can be confusing. There has also been confusion for the term HNS, also known as “HANKS” or HHNKS, or HNC,” which will be clarified. 

Program Information

Objectives

  1. Identify the three diabetic emergencies as hypoglycemia, DKA and HNKS.   
  2. Discuss the presenting signs and symptoms, pathophysiology, risk factors, and diagnostic tests for the three diabetic emergencies.  
  3. Explain the medical treatment and management protocol for each diabetic emergency.

Outline


Overview of pathophysiology and classifications of Diabetes Mellitus. 

Hypoglycemia:  

  • Clinical presentation  
  • Causes and risk factors 
  • Diagnostic tests and criteria 
  • Emergency treatment 
  • Pharmacological management 
  • ADA standards 
  • Case study 

Diabetic Ketoacidosis:  

  • Clinical presentation  
  • Causes and risk factors 
  • Diagnostic tests and criteria 
  • Emergency treatment 
  • Pharmacological management 
  • ADA standards 
  • Case study 

 

Hyperosmolar Hyperglycemic Nonketotic Syndrome:  

  • Clinical presentation  
  • Causes and risk factors 
  • Diagnostic tests and criteria 
  • Emergency treatment 
  • Pharmacological management 
  • ADA standards 
  • Case study 

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants

Copyright : 09/12/2023

Preventing Amputation in Patients with Diabetes

This class is tailored for clinicians seeking to expand their expertise in diabetic food care, with a focus on preventing amputations. Participants will delve into comprehensive strategies for early detection, foot assessment, prevention strategies, and patient education. You will be equipped with the knowledge and skills necessary to reduce amputation rates among diabetic patients.

Program Information

Objectives

  1. Analyze the relationship between preventing foot ulcers and preventing infections, hospitalizations and amputations.
  2. Determine the methods of taking the A1c and the value of the collected data.
  3. Identify the necessary components of a short, focused history and thorough comprehensive diabetic foot assessment without taking shortcuts or skipping steps in the exam.
  4. Identify peripheral artery disease (PAD), loss of protective sensation (LOPS) and pedal deformities of bone, soft tissue and nails.
  5. Analyze four risk categories of the IWGDF for the diabetic foot and the value of each category for population health.
  6. Explain the strategy to prevent “category creep.”

Outline

Diabetes and Foot Ulcers

  • Why and how do the comorbid conditions develop?
  • Risk factors for developing a foot ulcer
  • Tips and approaches for A1c test … finger stick vs. CGM monitor … what does the data mean?
Primary Care Provider
  • Role in evaluating and managing the diabetic foot
  • Guiding principles of care for people with or at risk for developing diabetes
  • Business model of medicine … development and management of comorbid diabetic conditions with a focus on the diabetic foot
Patient Stratification
  • Prediabetes/Type 1/Type 2
  • Reversing and preventing prediabetes … risk factors for type 1 and type 2 diabetes
  • Insulin resistance as a precursor to type 2 diabetes … and how to reverse it
International Working Group on the Diabetic Foot (IWGDF) Criteria
  • IWGDF risk stratification scheme
  • Why categorize patients into one of the four risk groups?
  • Preventing “category creep”
DFU and Amputation
  • Causes of DFU and the relationship between DFU and amputations
  • Charcot foot
  • Neuropathy, Loss of protective sensation (LOPS), PAD, traumatic triggering events, and pedal deformities
Diabetic Foot Exam … Value of the IWGDF foot exam and the components of the exam

Prevention of DFU, Amputations and Risk Mitigation
  • Future of ulcer and amputation prevention

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physician Assistants

Copyright : 12/07/2023

Anti-Obesity Medication Treatments: Clinical Pearls for Prescribers

Anti-Obesity Medication Treatments: Clinical Pearls for Prescribers explores the pathophysiology of obesity, current FDA-approved anti-obesity medications, and their mechanisms of action to equip providers with the knowledge to select and manage patients with obesity confidently. Ahunna Freeman, PharmD, BCGP, will highlight valuable clinical pearls and include interactive patient cases to optimize patient outcomes in the management of obesity.

Program Information

Objectives

  1. Evaluate the epidemiology and pathophysiology of obesity.
  2. Determine clinical practice guidelines in the management of obesity in adults.
  3. Analyze FDA-approved pharmacologic options for the management of obesity.
  4. Develop appropriate therapeutic approaches for patient cases.

Outline

Epidemiology/Pathophysiology of Obesity

  • Obesity as a chronic, multifactorial condition with health consequences
  • Factors that affect or contribute to obesity
  • Limitations of lifestyle interventions in the management of obesity
Mechanism of Action for Anti-Obesity Medications (AOMs)
  • Explain the physiology of weight regulation
    • Patient: Caloric deficit, physical activity, stress management/psychologically
    • Metabolic adaptation: Hormones & metabolism
  • Treatment guidelines: Non-pharmacological and pharmacological options
  • Role of AOMs in weight management
Key Medications in the Management of Obesity
  • Clinical pearls of each FDA-approved AOM:
    • Initiating dose and formulations
    • Therapeutic strength
    • FDA-approved criteria
    • Potential adverse effects
    • Monitoring plans
    • Use in special populations/individualized treatment based on comorbidities
    • Use with other medications/potential interactions
    • Approximate Cost
Study trial results for the newest class of AOMs for clinical significance

Highlights from current research on AOMs

Target Audience

  • Nurse Practitioners
  • Nurses
  • Physician Assistants
  • Physicians
  • Pharmacists

Copyright : 10/24/2024

Management of Type 2 Diabetes

In this session, Matthew will discuss the two main treatment approaches for managing Type 2 Diabetes in a primary care setting. Starting with an overview of the complications, he will focus on the treatment approaches, and A1C guidelines. He will discuss both necessary lifestyle changes, including diet, and improving exercise/activity level. Additionally, he will cover the oral medicines for initial treatment and when insulin may be needed. Long term goals for treatment will be discussed to decrease the chance for heart failure, neuropathy and other complications.

Program Information

Objectives

  1. Integrate the pathophysiology of T2D into the development of a management plan.
  2. Educate patients on any medications prescribed for control of T2D.
  3. Implement the ADA T2D clinical practice guidelines to improve outcomes for patients.

Outline

  • Complications
    • Macrovascular
    • Microvascular
    • Neuropathy complications
  • Treatment
    • A1C Goals
    • Medications (ADA Guidelines) --cost of medications
    • Patient teaching Reduction of ASCVD Risks
  • Goals
    • Reduced HF Risk
    • Reduce risk of Neuropathy
    • Increased quality of Life

Target Audience

  • Nurses
  • Nurse Practitioners
  • Clinical Nurse Specialists
  • Physicians
  • Physician Assistants

Copyright : 01/06/2023

It’s All About the Food: Improving Diabetes Outcomes

Health care professionals often find themselves having to dispense recommendations about nutrition against a backdrop of rampant misinformation. Learn the latest guidelines about healthy eating with diabetes and which eating patterns are associated with the best outcomes.  Common misconceptions about meal planning for diabetes will be exposed and you’ll learn how to expertly address today’s hottest topics like keto and artificial sweeteners.

Program Information

Objectives

  1. Determine the key parameters for effective medical nutrition therapy in people with diabetes.
  2. Evaluate the metabolic impact of macronutrients on blood glucose levels.
  3. Analyze the use of various eating patterns on health outcomes in persons with diabetes.
  4. Assess the guidelines for weight management in diabetes.

Outline

  • Diet Tribes: Which Diet is Best for Diabetes?
    • Examining the evidence
  • Nutrient Know-How: How they impact blood sugar
    • Is there an ideal macronutrient ratio?
  • Hot topics: EXPOSED!
    • Misconceptions about meal planning
    • The use of artificial sweeteners
    • Role of carbohydrate in the overall diet
  • Locking in Behavior Change
    • Meal planning tips
    • Medical nutrition therapy guidelines
    • Common resources

Target Audience

  • Nurses
  • Occupational Therapists
  • Occupational Therapy Assistants
  • Physicians

Copyright : 12/15/2022